1. Medtech Insight

Smile Train And BioDigital Introduce App To Train Surgeons In Cleft Palate Repair

 
• By Marion Webb

Smile Train introduces a new mobile app to accelerate much-needed virtual surgical training for cleft-lip and palate repair.  

Cleft Palate Repair

Smile Train, a nonprofit organization and that provides free corrective cleft surgery in 87 countries with more than 1,000 partner surgeons, and its long-time technology partner, Biodigital Inc., recently launched a new mobile app to bring its 3D-based virtual surgical training simulator to doctors in even the most remote areas.

“Cleft-lip and palate is the most common birth defect affecting the face,” said Roberto Flores, medical director of the Virtual Surgery Simulator who is also the director of cleft lip...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Digital Technologies

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.